missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human GCLC (aa 436-536) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (96%), Rat (96%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-83330. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase is the first rate-limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subunit and a light regulatory subunit. This locus encodes the catalytic subunit, while the regulatory subunit is derived from a different gene located on chromosome 1p22-p21. Mutations at this locus have been associated with hemolytic anemia due to deficiency of gamma-glutamylcysteine synthetase and susceptibility to myocardial infarction.
Specifications
Specifications
| Accession Number | P48506 |
| Concentration | 0.8 mg/mL |
| For Use With (Application) | Neutralization, Control |
| Formulation | PBS, 1M urea with no preservative; pH 7.4 |
| Gene ID (Entrez) | 2729 |
| Name | Human GCLC (aa 436-536) Control Fragment |
| pH Range | 7.4 |
| Purification Method | Purified |
| Quantity | 100 μL |
| Storage Requirements | -20°C, Avoid Freeze/Thaw Cycles |
| Show More |